Involvement of Rel/NF-κB transcription factors in senescence

Experimental Gerontology

Volumn 38, Issue 11-12, 2003, Pages 1271-1283

  Gosselin, Karo ^a   Abbadie, Corinne ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P50; PROTEIN P52; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB;

APOPTOSIS; CARCINOGENESIS; CELL AGING; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; CORRELATION ANALYSIS; ENERGY METABOLISM; GENE ACTIVITY; GENE EXPRESSION; GENE TARGETING; IMMUNITY; IN VITRO STUDY; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SENESCENCE; STRESS; TRANSCRIPTION INITIATION;

EID: 0348047392     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2003.09.007     Document Type: Article

References (214)

1. Abbadie C., Kabrun N., Bouali F., Smardova J., Stéhelin D., Vandenbunder B., Enrietto P. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell. 75:1993;899-912.
2. Aggarwal B.B., Totpal K., LaPushin R., Chaturvedi M.M., Pereira-Smith O.M., Smith J.R. Diminished responsiveness of senescent normal human fibroblasts to TNF-dependent proliferation and interleukin production is not due to its effect on the receptors or on the activation of a nuclear factor-kappaB. Exp. Cell Res. 218:1995;381-388.
3. Anisowicz A., Messineo M., Lee S.W., Sager R. An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J. Immunol. 147:1991;520-527.
4. Arakawa T., Nakamura M., Yoshimoto T., Yamamoto S. The transcriptional regulation of human arachidonate 12-lipoxygenase gene by NF-kappaB/Rel. FEBS Lett. 363:1995;105-110.
5. Azimi N., Brown K., Bamford R.N., Tagaya Y., Siebenlist U., Waldmann T.A. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc. Natl Acad. Sci. USA. 95:1998;2452-2457.
6. Baraldi-Junkins C.A., Beck A.C., Rothstein G. Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol. Oncol. Clin. North Am. 14:2000;45-61. viii.
7. Barger S.W., Horster D., Furukawa K., Goodman Y., Krieglstein J., Mattson M.P. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappaB-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl Acad. Sci. USA. 92:1995;9328-9332.
8. Bash J., Zong W., Gélinas C. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol. Cell Biol. 17:1997;6526-6536.
9. Bazan N.G., Colangelo V., Lukiw W.J. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat. 68-69:2002;197-210.
10. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-KB. Nature. 376:1995;167-170.
11. Benvenuti S., Cramer R., Bruce J., Waterfield M.D., Jat P.S. Identification of novel candidates for replicative senescence by functional proteomics. Oncogene. 21:2002;4403-4413.
12. Benvenuti S., Cramer R., Quinn C.C., Bruce J., Zvelebil M., Corless S., Bond J., Yang A., Hockfield S., Burlingame A.L., Waterfield M.D., Jat P.S. Differential proteome analysis of replicative senescence in rat embryo fibroblasts. Mol. Cell Proteomics. 1:2002;280-292.
13. Benz D., Cadet P., Mantione K., Zhu W., Stefano G. Tonal nitric oxide and health-a free radical and a scavenger of free radicals. Med. Sci. Monit. 8:2002;RA1-RA4.
14. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272:1997;20313-20316.
15. Bernard, D., Gosselin, K., Monte, D., Vercamer, C., Bouali, F., Pourtier, A., Vandenbunder, B., Abbadie, C., Involvement of Rel/NF-kappaB transcription factors in keratinocyte senescence. Cancer Research. (in revision).
16. Bernard D., Quatannens B., Begue A., Vandenbunder B., Abbadie A. Anti-proliferative and anti-apoptotic effects of cRel may occur within the same cells via the up-regulation of MnSOD. Cancer Res. 61:2001;2656-2664.
17. Bernard D., Quatannens B., Vandenbunder B., Abbadie C. Rel/NF-kappa B transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1. J. Biol. Chem. 276:2001;27322-27328.
18. Bernard D., Slomianny C., Vandenbunder B., Abbadie C. cRel induces mitochondrial alterations in correlation with proliferation arrest. Free Radical Biol. Med. 31:2001;943-953.
19. Bernard D., Monte D., Vandenbunder B., Abbadie C. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD. Oncogene. 21:2002;4392-4402.
20. Bhatt N.Y., Kelley T.W., Khramtsov V.V., Wang Y., Lam G.K., Clanton T.L., Marsh C.B. Macrophage-colony-stimulating factor-induced activation of extracellular-regulated kinase involves phosphatidylinositol 3-kinase and reactive oxygen species in human monocytes. J. Immunol. 169:2002;6427-6434.
21. Bonizzi G., Piette J., Merville M.P., Bours V. Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. Biochem. Pharmacol. 59:2000;7-11.
22. Brach M.A., Henschler R., Mertelsmann R.H., Herrmann F. Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF-kappaB. Pathobiology. 59:1991;284-288.
23. Brady T.C., Chang L.Y., Day B.J., Crapo J.D. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-kappaB activation. Am. J. Physiol. 273:1997;L1002-L1006.
24. Brantley D.M., Chen C.L., Muraoka R.S., Bushdid P.B., Bradberry J.L., Kittrell F., Medina D., Matrisian L.M., Kerr L.D., Yull F.E. Nuclear factor-kappaB regulates proliferation and branching in mouse mammary epithelium. Mol. Biol. Cell. 12:2001;1445-1455.
25. Brasier A.R., Ron D., Tate J.E., Habener J.F. A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF-kappaB mediated trans-activation of the angiotensinogen gene acute-phase response element. EMBO J. 9:1990;3933-3944.
26. Brown R.T., Ades I.Z., Nordan R.P. An acute phase response factor/NF-kappaB site downstream of the junB gene that mediates responsiveness to interleukin-6 in a murine plasmacytoma. J. Biol. Chem. 270:1995;31129-31135.
27. Bruunsgaard H., Pedersen M., Pedersen B.K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8:2001;131-136.
28. Bussolati B., Mariano F., Cignetti A., Guarini A., Cambi V., Foa R., Piccoli G., Camussi G. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. J. Immunol. 161:1998;1493-1500.
29. Caamano J., Hunter C.A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 15:2002;414-429.
30. Caffrey J.L., Boluyt M.O., Younes A., Barron B.A., O'Neill L., Crow M.T., Lakatta E.G. Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat. J. Mol. Cell Cardiol. 26:1994;701-711.
31. Cazals V., Nabeyrat E., Corroyer S., de Keyzer Y., Clement A. Role for NF-kappa B in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells. Biochim. Biophys. Acta. 1448:1999;349-362.
32. Chan H., Bartos D.P., Owen-Schaub L.B. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol. Cell Biol. 19:1999;2098-2108.
33. Chaturvedi V., Qin J.-Z., Denning M.F., Choubey D., Diaz M.O., Nickoloff B.J. Apoptosis in proliferating, senescent, and immortalized keratinocytes. J. Biol. Chem. 274:1999;23358-23367.
34. Chen L.C., Pace J.L., Russell S.W., Morrison D.C. Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Infect. Immun. 64:1996;4288-4298.
35. Chung H.Y., Kim H.J., Shim K.H., Kim K.W. Dietary modulation of prostanoid synthesis in the aging process: role of cyclooxygenase-2. Mech. Ageing Dev. 111:1999;97-106.
36. Collart M.A., Baeuerle P., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappaB-like motifs and of constitutive and inducible forms of NF-kappaB. Mol. Cell Biol. 10:1990;1498-1506.
37. Cominacini L., Pasini A.F., Garbin U., Davoli A., Tosetti M.L., Campagnola M., Rigoni A., Pastorino A.M., Lo Cascio V., Sawamura T. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. 275:2000;12633-12638.
38. Cusack J.C. Jr, Liu R., Baldwin A.S. Jr. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]- carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation. Cancer Res. 60:2000;2323-2330.
39. Dajee M., Lazarov M., Zhang J.Y., Cai T., Green C.L., Russell A.J., Marinkovich M.P., Tao S., Lin Q., Kubo Y., Khavari P.A. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 421:2003;639-643.
40. Das K.C., Lewis-Molock Y., White C.W. Thiol modulation of TNF alpha and IL-1 induced MnSOD gene expression and activation of NF-kappaB. Mol. Cell Biochem. 148:1995;45-57.
41. DePinho R.A. The age of cancer. Nature. 408:2000;248-254.
42. Dierick J.F., Kalume D.E., Wenders F., Salmon M., Dieu M., Raes M., Roepstorff P., Toussaint O. Identification of 30 protein species involved in replicative senescence and stress-induced premature senescence. FEBS Lett. 531:2002;499-504.
43. Dimri G.P., Campisi J. Altered profile of transcription factor-binding activities in senescent human fibroblasts. Exp. Cell Res. 212:1994;132-140.
44. Doi T.S., Marino M.W., Takahashi T., Yoshida T., Sakakura T., Old L.J., Obata Y. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc. Natl Acad. Sci USA. 96:1999;2994-2999.
45. Dopp J.M., Sarafian T.A., Spinella F.M., Kahn M.A., Shau H., de Vellis J. Expression of the p75 TNF receptor is linked to TNF-induced NF-kappaB translocation and oxyradical neutralization in glial cells. Neurochem. Res. 27:2002;1535-1542.
46. Duyao M.P., Kessler D.J., Spicer D.B., Bartholomew C., Cleveland J.L., Siekevitz M., Sonenshein G.E. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF-kappaB. J. Biol. Chem. 267:1992;16288-16291.
47. Feuillard J., Memet S., Goudeau B., Lilienbaum A., Schmidt-Ullrich R., Raphael M., Israel A. In vivo identification of lymphocyte subsets exhibiting transcriptionally active NF-kappaB/Rel complexes. Int. Immunol. 12:2000;613-621.
48. Gapuzan M.E., Yufit P.V., Gilmore T.D. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype. Oncogene. 21:2002;2484-2492.
49. Garcia-Nogales P., Almeida A., Fernandez E., Medina J.M., Bolanos J.P. Induction of glucose-6-phosphate dehydrogenase by lipopolysaccharide contributes to preventing nitric oxide-mediated glutathione depletion in cultured rat astrocytes. J. Neurochem. 72:1999;1750-1758.
50. Geller D.A., Lowenstein C.J., Shapiro R.A., Nussler A.K., Di Silvio M., Wang S.C., Nakayama D.K., Simmons R.L., Snyder S.H., Billiar T.R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl Acad. Sci. USA. 1993.
51. Ghosh S., May M., Kopp E. NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
52. Giardina C., Hubbard A.K. Growing old with nuclear factor-kappaB. Cell Stress Chaperones. 7:2002;207-212.
53. Gilmore T.D. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene. 18:1999;6925-6937.
54. Gilmore T.D., Cormier C., Jean-Jacques J., Gapuzan M.E. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene. 20:2001;7098-7103.
55. Golden T.R., Hinerfeld D.A., Melov S. Oxidative stress and aging: beyond correlation. Aging Cell. 1:2002;117-123.
56. Goldman R., Moshonov S., Zor U. Calcium-dependent PAF-stimulated generation of reactive oxygen species in a human keratinocyte cell line. Biochim. Biophys. Acta. 1438:1999;349-358.
57. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science. 249:1990;1129-1133.
58. Goodman L., Stein G.H. Basal and induced amounts of interleukin-6 mRNA decline progressively with age in human fibroblasts. J. Biol. Chem. 269:1994;0-5.
59. Greene E.L., Velarde V., Jaffa A.A. Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension. 35:2000;942-947.
60. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W., Gerondakis S. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:1998;663-674.
61. Grumont R.J., Rourke I.J., Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:1999;400-411.
62. Gugasyan R., Grumont R., Grossmann M., Nakamura Y., Pohl T., Nesic D., Gerondakis S. Rel/NF-kappaB transcription factors: key mediators of B-cell activation. Immunol. Rev. 176:2000;134-140.
63. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol. 19:1999;5785-5799.
64. Hanazawa T., Antuni J.D., Kharitonov S.A., Barnes P.J. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J. Allergy Clin. Immunol. 105:2000;58-64.
65. Hannink M., Temin H.M. Structure and autoregulation of the c-rel promoter. Oncogene. 5:1990;1843-1850.
66. Hayashi T., Ueno Y., Okamoto T. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:1993;11380-11388.
67. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:1965;614-636.
68. Hein H., Schluter C., Kulke R., Christophers E., Schroder J.M., Bartels J. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem. Biophys. Res. Commun. 237:1997;537-542.
69. Helenius M., Hanninen M., Lehtinen S.K., Salminen A. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem. J. 318:1996;603-608.
70. Helenius M., Makelainen L., Salminen A. Attenuation of NF-kappaB signaling response to UVB light during cellular senescence. Exp. Cell Res. 248:1999;194-202.
71. Helenius M., Kyrylenko S., Vehvilainen P., Salminen A. Characterization of aging-associated up-regulation of constitutive nuclear factor-kappaB binding activity. Antioxid Redox Signal. 3:2001;147-156.
72. Hettmann T., DiDonato J., Karin M., Leiden J.M. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189:1999;145-158.
73. Heymes C., Swynghedauw B., Chevalier B. Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats. Circulation. 90:1994;1328-1333.
74. Hiscott J., Marois J., Garoufalis J., D'Addario M., Roulston A., Kwan I., Pepin N., Lacoste J., Nguyen H., Bensi G., et al. Characterization of a functional NF-kappaB site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell Biol. 13:1993;6231-6240.
75. van Hogerlinden M., Rozell B.L., Ahrlund-Richter L., Toftgard R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 59:1999;3299-3303.
76. Homandberg G.A., Hui F., Wen C. Fibronectin fragment mediated cartilage chondrolysis I. Suppression by anti-oxidants. Biochim. Biophys. Acta. 1317:1996;134-142.
77. Hoyos B., Ballard D.W., Bohnlein E., Siekevitz M., Greene W.C. KappaB-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science. 244:1989;457-460.
78. Hu Y., Baud V., Delhase M., Zhang P., Deerinck T., Ellisman M., Johnson R., Karin M. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKa subunit of IkappaB kinase. Science. 284:1999;316-320.
79. Huang S., DeGuzman A., Bucana C.D., Fidler I.J. Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin. Cancer Res. 6:2000;2573-2581.
80. Huang Y., Johnson K.R., Norris J.S., Fan W. Nuclear factor-kappaB/ IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res. 60:2000;4426-4432.
81. Huguet C., Mattot V., Bouali F., Stéhelin D., Vandenbunder B., Abbadie C. The avian transcription factor c-Rel is induced and translocates into the nucleus of thymocytes undergoing apoptosis. Cell Death Differ. 4:1997;413-422.
82. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B., Hirsch E.C. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19:1999;3440-3447.
83. Ikebe T., Jimi E., Beppu M., Takeuchi H., Nakayama H., Shirasuna K. Aging-dependent proteolysis of NF-kappaB in human fibroblasts. J. Cell Physiol. 182:2000;247-255.
84. Irving J., Feng J., Wistrom C., Pikaart M., Villeponteau B. An altered repertoire of fos/jun (AP-1) at the onset of replicative senescence. Exp. Cell Res. 202:1992;161-166.
85. Israel A. The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol. 10:2000;129-133.
86. Israel A., Le Bail O., Hatat D., Piette J., Kieran M., Logeat F., Wallach D., Fellous M., Kourilsky P. TNF stimulates expression of mouse MHC class I genes by inducing an NF-kappaB-like enhancer binding activity which displaces constitutive factors. EMBO J. 8:1989;3793-3800.
87. Israel N., Gougerot-Pocidalo M.A., Aillet F., Virelizier J.L. Redox status of cells influences constitutive or induced NF-kappaB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149:1992;3386-3393.
88. Jazwinski M. Longevity, genes, and aging. Science. 273:1996;54-59.
89. Jazwinski S.M. Metabolic control and ageing. Trends Genet. 16:2000;506-511.
90. Kaufman C.K., Fuchs E. Its got you covered NF-kappaB in the epidermis. J. Cell Biol. 149:2000;999-1004.
91. Khachigian L.M., Resnick N., Gimbrone M.A. Jr., Collins T. Nuclear factor-kappaB interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J. Clin. Invest. 96:1995;1169-1175.
92. Kim H.J., Kim K.W., Yu B.P., Chung H.Y. The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radical Biol. Med. 28:2000;683-692.
93. Kim J.H., Choy H.E., Nam K.H., Park S.C. Transglutaminase-mediated crosslinking of specific core histone subunits and cellular senescence. Ann. NY Acad. Sci. 928:2001;65-70.
94. Kim J.M., Chung Y.H., Shin C.M., Kim M.J., Lee K.W., Cha C.I. Spatial and temporal distribution of Bax in rat spinal cord during normal aging. Neurol. Res. 23:2001;83-86.
95. Kiningham K.K., Xu Y., Daosukho C., Popova B., St Clair D.K. Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem. J. 353:2001;147-156.
96. Köntgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1995;1965-1965.
97. Korhonen P., Helenius M., Salminen A. Age-related changes in the regulation of transcription factor NF-kappaB in rat brain. Neurosci. Lett. 225:1997;61-64.
98. Kothny-Wilkes G., Kulms D., Luger T.A., Kubin M., Schwarz T. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis. J. Biol. Chem. 274:1999;28916-28921.
99. Kunsch C., Rosen C.A. NF-kappaB subunit-specific regulation of the interleukin-8 promoter. Mol. Cell Biol. 13:1993;6137-6146.
100. Lavrovsky Y., Song C.S., Chatterjee B., Roy A.K. Age-dependent increase of heme oxygenase-1 gene expression in the liver mediated by NF-kappaB. Mech. Ageing Dev. 114:2000;49-60.
101. Lee H.H., Dadgostar H., Cheng Q., Shu J., Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl Acad. Sci. USA. 96:1999;9136-9141.
102. Lenaz G., Bovina C., D'Aurelio M., Fato R., Formiggini G., Genova M.L., Giuliano G., Pich M.M., Paolucci U., Castelli G.P., Ventura B. Role of mitochondria in oxidative stress and aging. Ann. NY Acad. Sci. 959:2002;199-213.
103. Li J., Schmidt A.M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 272:1997;16498-16506.
104. Li J.J., Oberley L.W., Fan M., Colburn N.H. Inhibition of AP-1 and NF-kappaB by manganese-containing superoxide dismutase in human breast cancer cells. Faseb J. 12:1998;1713-1723.
105. Li Q., Van Antwerp D., Mercurio F., Lee K.-F., Verma I.M. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science. 284:1999;321-324.
106. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell Biol. 10:1990;2327-2334.
107. Licinio J., Prolo P., McCann S.M., Wong M.L. Brain iNOS: current understanding and clinical implications. Mol. Med. Today. 5:1999;225-232.
108. Lilienbaum A., Duc Dodon M., Alexandre C., Gazzolo L., Paulin D. Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene. J. Virol. 64:1990;256-263.
109. Lindau-Shepard B., Shaffer J.B., Del Vecchio P.J. Overexpression of manganous superoxide dismutase (MnSOD) in pulmonary endothelial cells confers resistance to hyperoxia. J. Cell Physiol. 161:1994;237-242.
110. Linskens M.H., Feng J., Andrews W.H., Enlow B.E., Saati S.M., Tonkin L.A., Funk W.D., Villeponteau B. Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res. 23:1995;3244-3251.
111. Liu Z., Hsu H., Goeddel D.V., Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:1996;565-576.
112. Lord J.M., Butcher S., Killampali V., Lascelles D., Salmon M. Neutrophil ageing and immunesenescence. Mech. Ageing Dev. 122:2001;1521-1535.
113. Lovat P.E., Oliverio S., Ranalli M., Corazzari M., Rodolfo C., Bernassola F., Aughton K., Maccarrone M., Hewson Q.D., Pearson A.D., Melino G., Piacentini M., Redfern C.P. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res. 62:2002;5158-5167.
114. Lukiw W.J., Bazan N.G. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J. Neurosci. Res. 53:1998;583-592.
115. Lundberg A.S., Hahn W.C., Gupta P., Weinberg R.A. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:2000;705-709.
116. Ly D.H., Lockhart D.J., Lerner R.A., Schultz P.G. Mitotic misregulation and human aging. Science. 287:2000;2486-2492.
117. Macera-Bloch L., Houghton J., Lenahan M., Jha K.K., Ozer H.L. Termination of lifespan of SV40-transformed human fibroblasts in crisis is due to apoptosis. J. Cell Physiol. 190:2002;332-344.
118. Marshall H.E., Stamler J.S. Nitrosative stress-induced apoptosis through inhibition of NF-kappa B. J. Biol. Chem. 277:2002;34223-34228.
119. Marshall H.E., Merchant K., Stamler J.S. Nitrosation and oxidation in the regulation of gene expression. Faseb J. 14:2000;1889-1900.
120. Matsui K., Fine A., Zhu B., Marshak-Rothstein A., Ju S.T. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161:1998;3469-3473.
121. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 24:1996;2236-2242.
122. Mattson M.P., Goodman Y. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676:1995;219-224.
123. Mejdoubi N., Henriques C., Bui E., Porquet D. NF-kappaB is involved in the induction of the rat hepatic alpha1-acid glycoprotein gene by phenobarbital. Biochem. Biophys. Res. Commun. 254:1999;93-99.
124. Mendes A.F., Caramona M.M., Carvalho A.P., Lopes M.C. Differential roles of hydrogen peroxide and superoxide in mediating IL- 1-induced NF-kappaB activation and iNOS expression in bovine articular chondrocytes. J. Cell Biochem. 88:2003;783-793.
125. Mettouchi A., Cabon F., Montreau N., Dejong V., Vernier P., Gherzi R., Mercier G., Binetruy B. The c-Jun-induced transformation process involves complex regulation of tenascin-C expression. Mol. Cell Biol. 17:1997;3202-3209.
126. Miller R.A. The aging immune system: primer and prospectus. Science. 273:1996;70-74.
127. Mirza A., Liu S.L., Frizell E., Zhu J., Maddukuri S., Martinez J., Davies P., Schwarting R., Norton P., Zern M.A. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am. J. Physiol. 272:1997;G281-G288.
128. Mori N., Gill P.S., Mougdil T., Murakami S., Eto S., Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood. 88:1996;1035-1045.
129. Moriuchi H., Moriuchi M., Fauci A.S. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158:1997;3483-3491.
130. Morri H., Ozaki M., Watanabe Y. 5′-flanking region surrounding a human cytosolic phospholipase A2 gene. Biochem. Biophys. Res. Commun. 205:1994;6-11.
131. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-kappa B half- site. Mol. Cell Biol. 15:1995;5258-5267.
132. Mutoh H., Ishii S., Izumi T., Kato S., Shimizu T. Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B. Biochem. Biophys. Res. Commun. 205:1994;1137-1142.
133. Nagase M., Abe J., Takahashi K., Ando J., Hirose S., Fujita T. Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J. Biol. Chem. 273:1998;33702-33707.
134. Ni A., Chao L., Chao J. Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. J. Biol. Chem. 273:1998;2784-2791.
135. Nitta T., Chiba A., Yamashita A., Rowe M., Israel A., Reth M., Yamamoto N., Yamaoka S. NF-kappaB is required for cell death induction by latent membrane protein 1 of Epstein-Barr virus. Cell. Signal. 15:2003;423-433.
136. Novak U., Cocks B.G., Hamilton J.A. A labile repressor acts through the NF-κB-like binding sites of the human urokinase gene. Nucleic Acids Res. 19:1991;3389-3393.
137. Pagliari L.J., Perlman H., Liu H., Pope R.M. Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol. Cell. Biol. 20:2000;8855-8865.
138. Pahl H.L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 18:1999;6853-6866.
139. Park S.K., Lin H.L., Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. Biochem. J. 322:1997;609-613.
140. Patel N.M., Nozaki S., Shortle N.H., Bhat-Nakshatri P., Newton T.R., Rice S., Gelfanov V., Boswell S.H., Goulet R.J., Sledge G.W., Nakshatri H. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaB-alpha super-repressor and parthenolide. Oncogene. 19:2000;4159-4169.
141. Peng H.B., Libby P., Liao J.K. Induction and stabilization of IkappaB-alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:1995;14214-14219.
142. Peng H.B., Spiecker M., Liao J.K. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J. Immunol. 161:1998;1970-1976.
143. Phelouzat M.A., Laforge T., Arbogast A., Quadri R.A., Boutet S., Proust J.J. Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors. Mech. Ageing Dev. 96:1997;35-46.
144. Rattner A., Korner M., Rosen H., Baeuerle P.A., Citri Y. Nuclear factor kappaB activates proenkephalin transcription in T lymphocytes. Mol. Cell. Biol. 11:1991;1017-1022.
145. Rayet B., Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 18:1999;6938-6947.
146. Richards M.L., Katz D.H. Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc epsilon RII (CD23): comparison with the germline epsilon promoter. J. Immunol. 158:1997;263-272.
147. Rinehart C.A., Watson J.M., Torti V.R., Palmieri D. The role of interleukin-1 in interactive senescence and age-related human endometrial cancer. Exp. Cell Res. 248:1999;599-607.
148. Romanov S.R., Kozakiewicz B.K., Holst C.R., Stampfer M.R., Haupt L.M., Tlsty T.D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 409:2001;633-637.
149. Rudolph D., Yeh W.C., Wakeham A., Rudolph B., Nallainathan D., Potter J., Elia A.J., Mak T.W. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14:2000;854-862.
150. Rutherford M.S., Baehler C.S., Richardson A. Genetic expression of complement factors and alpha1-acid glycoprotein by liver tissue during senescence. Mech. Ageing Dev. 35:1986;245-254.
151. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. Role of NF-kappaB in p53-mediated programmed cell death. Nature. 404:2000;892-897.
152. Sanz C., Benet I., Richard C., Badia B., Andreu E.J., Prosper F., Fernandez-Luna J.L. Antiapoptotic protein Bcl-x(L) is up-regulated during megakaryocytic differentiation of CD34(+) progenitors but is absent from senescent megakaryocytes. Exp. Hematol. 29:2001;728-735.
153. Sattler M., Winkler T., Verma S., Byrne C.H., Shrikhande G., Salgia R., Griffin J.D. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood. 93:1999;2928-2935.
154. Schmidt-Supprian M., Bloch W., Courtois G., Addicks K., Israel A., Rajewsky K., Pasparakis M. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell. 5:2000;981-992.
155. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5:1999;554-559.
156. Schoonbroodt S., Ferreira V., Best-Belpomme M., Boelaert J.R., Legrand-Poels S., Korner M., Piette J. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of IkappaB-alpha in NF-kappa B activation by an oxidative stress. J. Immunol. 164:2000;4292-4300.
157. Schoonbroodt S., Piette J. Oxidative stress interference with the nuclear factor-kappaB activation pathways. Biochem. Pharmacol. 60:2000;1075-1083.
158. Schreck R., Baeuerle P.A. NF-kappaB as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol. 10:1990;1281-1286.
159. Schwarze S.R., DePrimo S.E., Grabert L.M., Fu V.X., Brooks J.D., Jarrard D.F. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J. Biol. Chem. 277:2002;14877-14883.
160. Seitz C.S., Lin Q., Deng H., Khavari P.A. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl Acad. Sci. USA. 95:1998;2307-2312.
161. Seitz C.S., Deng H., Hinata K., Lin Q., Khavari P.A. Nuclear factor-kappaB subunits induce epithelial cell growth arrest. Cancer Res. 60:2000;4085-4092.
162. Sekkai D., Aillet F., Israel N., Lepoiure M. Inhibition of NF-kappaB and HIV-1 long terminal repeat transciptional activation by inducible nitric oxide synthase 2 activity. J. Biol. Chem. 273:1998;3895-3900.
163. Seluanov A., Gorbunova V., Falcovitz A., Sigal A., Milyavsky M., Zurer I., Shohat G., Goldfinger N., Rotter V. Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. Mol. Cell. Biol. 21:2001;1552-1564.
164. Semov A., Marcotte R., Semova N., Ye X., Wang E. Microarray analysis of E-box binding-related gene expression in young and replicatively senescent human fibroblasts. Anal. Biochem. 302:2002;38-51.
165. Serfling E., Barthelmas R., Pfeuffer I., Schenk B., Zarius S., Swoboda R., Mercurio F., Karin M. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:1989;465-473.
166. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., Jongeneel C.V. KappaB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med. 171:1990;35-47.
167. Shay J.W., Pereira-Smith O.M., Wright W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196:1991;33-39.
168. Shelton D.N., Chang E., Whittier P.S., Choi D., Funk W.D. Microarray analysis of replicative senescence. Curr. Biol. 9:1999;939-945.
169. Sherwood E.M., Xu W., Riley R.L. B cell precursors in senescent mice exhibit decreased recruitment into proliferative compartments and altered expression of Bcl-2 family members. Mech. Ageing Dev. 124:2003;147-153.
170. Shin W.S., Hong Y.H., Peng H.B., De Caterina R., Libby P., Liao J.K. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J. Biol. Chem. 271:1996;11317-11324.
171. Shou Y., Li N., Li L., Borowitz J.L., Isom G.E. NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis. J. Neurochem. 81:2002;842-852.
172. Smith J.R., Pereira-Smith O.M. Replicative senescence: implications for in vivo aging and tumor suppression. Science. 273:1996;63-67.
173. Sohur U.S., Chen C.L., Hicks D.J., Yull F.E., Kerr L.D. Nuclear factor-kappaB/Rel is apoptogenic in cytokine withdrawal-induced programmed cell death. Cancer Res. 60:2000;1202-1205.
174. Spaulding C., Guo W., Effros R.B. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp. Gerontol. 34:1999;633-644.
175. Spencer N.F., Poynter M.E., Im S.Y., Daynes R.A. Constitutive activation of NF-kappaB in an animal model of aging. Int. Immunol. 9:1997;1581-1588.
176. van de Stolpe A., Caldenhoven E., Stade B.G., Koenderman L., Raaijmakers J.A., Johnson J.P., van der Saag P.T. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J. Biol. Chem. 269:1994;6185-6192.
177. Supakar P.C., Jung M.H., Song C.S., Chatterjee B., Roy A.K. Nuclear factor-kappaB functions as a negative regulator for the rat androgen receptor gene and NF-kappaB activity increases during the age-dependent desensitization of the liver. J. Biol. Chem. 270:1995;837-842.
178. Suzuki Y., Ono Y., Hirabayashi Y. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett. 425:1998;209-212.
179. Swift M.E., Burns A.L., Gray K.L., DiPietro L.A. Age-related alterations in the inflammatory response to dermal injury. J. Invest. Dermatol. 117:2001;1027-1035.
180. Takeda K., Takeuchi O., Tsujimura T., Itami S., Adachi O., Kawai T., Sanjo H., Yoshikawa K., Terada N., Akira S. Limb and skin abnormalities in mice lacking IKKa. Science. 284:1999;313-316.
181. Thannickal V.J., Day R.M., Klinz S.G., Bastien M.C., Larios J.M., Fanburg B.L. Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-beta1. Faseb J. 14:2000;1741-1748.
182. Tian W.N., Braunstein L.D., Apse K., Pang J., Rose M., Tian X., Stanton R.C. Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am. J. Physiol. 276:1999;C1121-C1131.
183. Toledano M.B., Leonard W.J. Modulation of transcription factor NF-kappaB binding activity by oxidation-reduction in vitro. Proc. Natl Acad. Sci. USA. 88:1991;4328-4332.
184. Toliver-Kinsky T., Papaconstantinou J., Perez-Polo J.R. Age-associated alterations in hippocampal and basal forebrain nuclear factor-kappaB activity. J. Neurosci. Res. 48:1997;580-587.
185. Toussaint O., Fuchs S.Y., Ronai Z.A., Isoyama S., Yuko N., Petronilli V., Bernardi P., Gonos E.S., Dumont P., Remacle J. Reciprocal relationships between the resistance to stresses and cellular aging. Ann. NY Acad. Sci. 851:1998;450-465.
186. delaTorre A., Schroeder R.A., Punzalan C., Kuo P.C. Endotoxin-mediated S-nitrosylation of p50 alters NF-kappaB-dependent gene transcription in ANA-1 murine macrophages. J. Immunol. 162:1999;4101-4108.
187. Trebilcock G.U., Ponnappan U. Nuclear factor-kappaB induction in CD45RO+ and CD45RA+T cell subsets during aging. Mech. Ageing Dev. 102:1998;149-163.
188. Tsukahara T., Kannagi M., Ohashi T., Kato H., Arai M., Nunez G., Iwanaga Y., Yamamoto N., Ohtani K., Nakamura M., Fujii M. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J. Virol. 73:1999;7981-7987.
189. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Hee Park S., Thompson T., Karsenty G., Bradley A., Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53.
190. Ueda A., Okuda K., Ohno S., Shirai A., Igarashi T., Matsunaga K., Fukushima J., Kawamoto S., Ishigatsubo Y., Okubo T. NF-kappaB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153:1994;2052-2063.
191. Untergasser G., Koch H.B., Menssen A., Hermeking H. Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Res. 62:2002;6255-6262.
192. Vafa O., Wade M., Kern S., Beeche M., Pandita T.K., Hampton G.M., Wahl G.M. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell. 9:2002;1031-1044.
193. Vollmar B., Pradarutti S., Nickels R.M., Menger M.D. Age-associated loss of immunomodulatory protection by granulocyte-colony stimulating factor in endotoxic rats. Shock. 18:2002;348-354.
194. Wang C.-Y., Cusack J.C., Liu R., Baldwin A.S. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med. 5:1999;412-417.
195. Wang C.Y., Mayo M.W., Baldwin A.S. Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 274:1996;784-787.
196. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 55:1995;2284-2292.
197. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 280:2001;E685-E694.
198. Weksler M.E., Schwab R. The immunogenetics of immune senescence. Exp. Clin. Immunogenet. 9:1992;182-187.
199. Widmer U., Manogue K.R., Cerami A., Sherry B. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. J. Immunol. 150:1993;4996-5012.
200. Williams W.M., Chang M.C., Rapoport S.I. Cerebral microvessel phospholipase A2 activity in senescent mouse. Neurochem. Res. 19:1994;317-320.
201. Worm M., Ebermayer K., Henz B. Lymphotoxin-alpha is an important autocrine factor for CD40+interleukin-4-mediated B-cell activation in normal and atopic donors. Immunology. 94:1998;395-402.
202. Wright K.L., White L.C., Kelly A., Beck S., Trowsdale J., Ting J.P. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J. Exp. Med. 181:1995;1459-1471.
203. Wu H., Lozano G. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269:1994;20067-20074.
204. Xanthoudakis S., Miao G., Wang F., Pan Y.C., Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11:1992;3323-3335.
205. Xia C., Hu J., Ketterer B., Taylor J.B. The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem. J. 313:1996;155-161.
206. Xiao Z.Q., Majumdar A.P. Induction of transcriptional activity of AP-1 and NF-kappaB in the gastric mucosa during aging. Am. J. Physiol. Gastrointest. Liver Physiol. 278:2000;G855-G865.
207. Xu X., Beckman I., Bradley J. Age-related changes in the expression of IL-2 and high-affinity IL-2 binding sites. Int. Arch. Allergy Immunol. 102:1993;224-231.
208. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor-kappaB and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270:1995;31315-31320.
209. Yan Z.Q., Sirsjo A., Bochaton-Piallat M.L., Gabbiani G., Hansson G.K. Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler. Thromb. Vasc. Biol. 19:1999;2854-2862.
210. Yao K.S., O'Dwyer P.J. Involvement of NF-kappaB in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol. 49:1995;275-282.
211. Yarom R., Sapoznikov D., Havivi Y., Avraham K.B., Schickler M., Groner Y. Premature aging changes in neuromuscular junctions of transgenic mice with an extra human CuZnSOD gene: a model for tongue pathology in Down's syndrome. J. Neurol. Sci. 88:1988;41-53.
212. Yim C.Y., Hibbs J.B. Jr, McGregor J.R., Galinsky R.E., Samlowski W.E. Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J. Immunol. 152:1994;5796-5805.
213. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res. 60:2000;4053-4057.
214. Zong W.X., Bash J., Gelinas C. Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect. Cell. Death Differ. 5:1998;963-972.